| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $18.8M | -2.3% | -42.4% |
| Cost of Revenue | $16.2M | -3.9% | -34.1% |
| R&D Expense | $442K | -52.7% | -61.9% |
| SG&A Expense | $5.7M | +40.0% | -9.2% |
| Operating Income | -$4.6M | -13.3% | -226.4% |
| Pre-tax Income | -$5.7M | -46.6% | -143.6% |
| Income Tax | $40K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $11.7M | -1.4% | +6.1% |
| Accounts Receivable | $7.7M | -8.1% | -45.7% |
| Inventory | $1.5M | +26.5% | -12.7% |
| Current Assets | $22.3M | -2.8% | -23.0% |
| Total Assets | $53.8M | +10.0% | -19.9% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$6.3M | -105.3% | — |
| Capital Expenditures | $1.8M | +80.8% | — |
| Investing Cash Flow | -$6.8M | -571.0% | — |
| Financing Cash Flow | $20.7M | +74.9% | — |
| Free Cash Flow | -$8.1M | -99.1% | — |
| — |
| +544.4% |
| Net Income | -$5.5M | -54.2% | -198.1% |
| EPS (Basic) | -$0.52 | -1200.0% | -2500.0% |
| $35.5M |
| +4.4% |
| -30.9% |
| Total Liabilities | $61.8M | +1.3% | +0.8% |
| Stockholders' Equity | -$16.2M | +22.1% | -248.5% |